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was detected in 9 P. irritans fleas (7 
male [6 unfed and 1 engorged] and 2 
[engorged] female) from 3 houses, in-
cluding the house where a confirmed 
human case of plague had occurred 
(online Technical Appendix, http://
wwwnc.cdc.gov/EID/article/20/8/13-
0629-Techapp1.pdf). Eight sequences 
(GenBank accession nos. KJ361938–
KJ361945) were obtained and share 
99% nucleotide homology with plas-
minogen activator genes of Y. pestis 
published in GenBank (accession nos. 
AF528537, AY305870). No Y. pestis 
was detected in the 24 S. fonquerniei, 
9 X. cheopis, 10 E. gallinacea, or 1 C. 
canis fleas collected. 
Although only X. cheopis and S. 
fonqueniei fleas had previously been 
described as plague vectors in Mada-
gascar, P. irritans fleas were most 
commonly collected during this field 
study; engorged and unfed male and 
female P. irritans fleas carried Y. pes-
tis. Other studies have found P. irri-
tans fleas in the plague risk area in oth-
er countries in Africa (5,6); one study 
found that P. irritans fleas may play a 
role in plague epidemiology in Tanza-
nia (5). Data on P. irritans fleas in rats 
make it unlikely that these fleas are 
involved in rat-to-human transmis-
sion of Y. pestis in Madagascar. Dur-
ing 1922–1995, a total of 118,608 rats 
were caught and examined in Mada-
gascar, but only 148 P. irritans fleas 
were identified, and none have been 
found on rats since 1996 (http://www.
pasteur.mg/spip.php?rubrique124). 
The high density of P. irritans fleas 
we observed in villages where plague 
outbreaks occurred in late 2012 and 
early 2013 (http://www.pasteur.mg/
spip.php?rubrique124) supports the 
possibility that P. irritans fleas played 
a role in domestic human-to-human 
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Serologic  
Surveillance for 
West Nile Virus  
in Dogs, Africa
To the Editor: West Nile fe-
ver is caused by the West Nile virus 
(WNV), a mosquito-borne member 
of the genus Flavivirus. Birds are 
the natural reservoir of the virus, 
which is maintained in nature in a 
mosquito–bird–mosquito transmis-
sion cycle. WNV has been detected 
in many regions worldwide, includ-
ing North America, Europe, Africa, 
the Near East, and Asia (1). WNV 
has been shown to cause meningoen-
cephalitis in humans and horses. In 
the United States, seroconversion in 
dogs was detected 6 weeks before a 
human case was reported (2). Thus, 
dogs could be considered as sentinels 
for WNV infection, but their role as 
reservoir is unlikely because of short-
term and low levels of viremia (3). 
In this study, we determined the se-
roprevalence of WNV in dogs living 
close to humans in different environ-
ments to assess their role as sentinels 
of this potentially severe zoonosis.
During 2003–2012, blood sam-
ples were collected from 753 adult 
dogs from France and 6 countries in 
Africa (Table). Samples were cen-
trifuged within 24 h after collection, 
separated, frozen at –20°C, and sent 
to the virology laboratory of the In-
stitut de Recherche Biomédicale des 
Armées (Marseille, France). Each 
sample was systematically tested for 
IgG against WNV by using an in-
house ELISA with inactivated WNV 
as antigen. Serum samples were con-
sidered positive if the optical density 
at 450 nm was >3-fold the mean of 
that for negative antigen. Because of 
the antigenic cross-reactivity among 
flaviviruses, all positive samples were 
further tested by Western blot for 
WNV-specific antibodies (4); serop-
revalence was calculated on the basis 
of Western blot–confirmed cases only. 
	 Emerging	Infectious	Diseases	•	www.cdc.gov/eid	•	Vol.	20,	No.	8,	August	2014	 1415
LETTERS
For the statistical analysis, we used 
the exact binomial method to calculate 
95% CIs of the proportions  and the 
Fisher exact test to calculate p values 
and compare the seroprevalence rates 
between countries; significance was 
set at p<0.05.
Seropositive dogs were found in 
all portions of Africa and France sur-
veyed except northeastern Gabon and 
Corsica (Table). Seroprevalence of 
WNV in native dogs was significant-
ly higher in Chad than in the Demo-
cratic Republic of the Congo (DRC) 
(p<0.001), Senegal (p<0.00001), 
Côte d’Ivoire (p<0.000001), and Ga-
bon (p<0.000001). Seroprevalence 
was low in Kinshasa, DRC (12.5%), 
and Dakar, Senegal (11.1%), but 
in N’Djamena, Chad, all 5 native 
dogs tested had specific antibodies 
against WNV. 
As part of the study, we tested 50 
military dogs from France twice, be-
fore and after a 4-month mission in 
Chad; 12 (24.0%) became seroposi-
tive after the stay. In addition, 12.5% 
of military working dogs in France 
imported from Hungary were seropos-
itive on initial testing. We also found 
that, in France, dogs are the sentinels 
of WNV circulation in the Var (12.0%) 
and Gard (9.1%) departments. All 
dogs we tested that were positive for 
IgG were negative for IgM, a finding 
that indicates infection by the virus 
did not occur recently.
The results and the statistical 
analysis reveal notable differences in 
the seroprevalence rates, according 
to the geographic area. N’Djamena, 
Chad, where all native dogs tested 
positive for WNV, is located at the 
confluence of the Chari and Logone 
Rivers and is an area with high densi-
ties of residential and migratory birds. 
In contrast, the northeastern region 
(Haut-Ogooué) of Gabon, where no 
native dogs tested positive for WNV, 
is an ecosystem of wet forests without 
migratory birds, unfavorable to virus 
circulation. In Dakar, 18.7% of na-
tive dogs were seropositive. In these 
central parts of Senegal, character-
ized by a semi-arid climate and veg-
etation composed of steppe plants and 
bluegrass, several WNV strains have 
been isolated from birds and mosqui-
toes. The seroprevalence was lower 
(0%–12.5%) in the sub-Saharan area, 
including Côte d’Ivoire, Gabon, DRC, 
and Senegal (Siné-Saloum and Casa-
mance), where the humid or semihu-
mid climate is linked with tropical rain 
forests or woodland savannah known 
to favor sedentary birds (5).
In a large proportion of the hu-
man and animal population of Africa, 
immunity to WNV has developed 
(1). A serologic survey of dogs from 
the Highveld region of South Africa 
showed that 37% (138/377) had neu-
tralizing antibodies against WNV (6). 
Similarly, seroprevalence of antibod-
ies against WNV is high among dogs 
in the United States, for example, 
55.9% (218/390) in the Gulf Coast 
region (7). In Turkey, an area where 
many birds stop over during migra-
tion, seroprevalence among dogs was 
high (37.7%, 43/114) (8).
Our study highlights the role of 
dogs as sentinels for WNV circula-
tion, particularly in southeastern 
France (Gard and Var departments), 
where WNV epidemics and epizo-
otics occurred in 2000 and 2003. In 
addition, we observed that military 
working dogs purchased from Hun-
gary, where WNV infection is com-
mon (9), may be seropositive. Sero-
conversion in dogs returning from 
short missions in WNV-endemic 
countries such as Chad was also ob-
served. Therefore, our data empha-
size the usefulness and convenience 
of WNV seroprevalence surveys in 
dogs for studying WNV epidemiol-
ogy and circulation. It is possible that 
dogs living close to humans could 












France     
 Corsica 35* 3 0 0	(0–10) 
 Var 25* 3 3 12.0	(2.5–31.2) 
 Gard 11* 1 1 9.1	(0.2–41.3) 
 Imported	from     
  Germany/the	Netherlands 9* 0 0 0	(0–33.6) 
  Hungary 24* 6 3 12.5	(2.7–32.4) 
Djibouti 47* 8 6 12.8	(4.8–25.7) 
N'Djamena,	Chad 50* 13 12 24.0	(13.1–38.2) 
 5 5 5 100.0	(47.8–100.0) 
Senegal     
 Dakar 11* 0 0 0	(0–28.5) 
 16† 3 3 18.7	(4.1–45.6) 
 Siné-Saloum 33 6 1 3.0	(0.1–15.8) 
 Casamance 81 3 3 3.7	(0.8–10.4) 
Abidjan, Côte d’Ivoire 137 7 3 2.2	(0.5–6.3) 
Kinshasa,	Democratic	Republic	of	the	Congo 24 4 3 12.5 (2.7–32.4) 
Haut-Ogooué,	Gabon 245 0 0 0	(0–1.5) 
*French	military	working	dogs. 
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Severe Encephalitis 
Caused by Toscana 
Virus, Greece
To the Editor: In late June 2012, 
a previously healthy, 49-year-old 
woman was admitted to the emergen-
cy department of Trikala General Hos-
pital in Trikala, Greece, with confu-
sion and delirium. A few hours before 
admission, she had had a grand mal 
seizure; she had experienced gastroen-
teritis with fever (38°C) 5 days earlier. 
On admission, she was intubated and 
transferred to the intensive care unit, 
where she underwent mechanical ven-
tilation and sedation. 
The patient was a resident of 
Genesi village (350 m altitude), 22 
km west of Trikala in the Thessaly 
region. She had not traveled abroad 
or to other area of Greece. Results 
of blood and cerebrospinal fluid 
(CSF) laboratory testing were unre-
markable except slight leukocytosis 
(leukocytes 11,330 cells/mm3, 92% 
neutrophils) and slightly elevated se-
rum lactate dehydrogenase level (240 
U/L). Brain imaging showed edema 
(online Technical Appendix, http://
wwwnc.cdc.gov/EID/article/20/8/14-
0248-Techapp1.pdf), which resolved 
48 hours after admission. The pa-
tient was awakened on day 3 of hos-
pitalization and extubated on day 4. 
Treatment included anticonvulsants, 
mannitol, antimicrobial drugs (van-
comycin and ceftriaxone), acyclovir, 
and corticosteroids. The patient fully 
recovered and was discharged from 
the hospital on day 12 with short-
term antiepileptic medication.
Because West Nile virus (WNV) 
infections emerged in 2010 in Greece 
and outbreaks have recurred (1), 
serum and CSF samples from the 
patient were sent for testing to the 
National Reference Centre for Ar-
boviruses. Antibodies against WNV 
were not detected. Reverse transcrip-
tion nested PCR was conducted by 










and	 cope	 with	 infection	 and	 illness.	
This	section	is	intended	to	evoke	com-
passion	 for	 human	 suffering	 and	 to	
expand	 the	 science	 reader’s	 literary	
scope.	 Manuscripts	 are	 selected	 for	
publication	 as	 much	 for	 their	 content	
(the	experiences	they	describe)	as	for	
their	literary	merit.
